Deborah J Marsh

13PUBLICATIONS
22CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Psychosocial aspects of childbirth and perinatal mental healthHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 09, 2026
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Yue Ma, Kristie-Ann Dickson, Farhana A Sarker

|Jan 05, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer.

Dongli Liu, Michelle Wong-Brown, Farhana Amy Sarker

|Aug 28, 2025
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens.

Tali S Skipper, Kristie-Ann Dickson, Christopher E Denes

|Sep 14, 2024
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant Subtypes.

Yue Ma, Natisha R Field, Tao Xie

|Jul 31, 2024
A survey of women diagnosed with breast cancer experiencing oncology treatment-induced hot flushes: identification of specific characteristics as predictors of hot flush occurrence, frequency, and severity.

Susan Gallagher, Alice Johnstone, Alysha De Livera

|Oct 28, 2023
PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics.

Glena Travis, Eileen M McGowan, Ann M Simpson

Pageof 3

Frequent Collaborators

7 joint publications

Kristie-Ann Dickson

4 joint publications

Yue Ma

3 joint publications

Nikola A Bowden

2 joint publications

Amani Alghalayini